BMAL1 and type 2 diabetes mellitus: Indeed, the risk of developing impaired fasting plasma glucose has been associated with polymorphisms in CRY2 [10,26,28] while the polymorphism in ARNTL has been reported to increase the susceptibility to develop type 2 diabetes [27].